Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Any-news about the meeting?

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Oct 29, 2020 1:06pm

122 Views

Post# 31804118

RE:RE:RE:RE:Any-news about the meeting?

I will defer to Qwerty, JFM and others with a deep medical understanding to amke comments about it. IT is not over yet but I thought Paul and Christian made the points they wanted to make. But they made too many points about Lipo, Trogarzo and cancer and that was wasting the time of the listeners as this is a NASH program. But I understand they are trying to introduce the whole company to the listeners - I just don't think it was needed or certainly could have been shortened considerably.